Effects of Artificial Sweetener on Gastrointestinal (GI) Peptide Secretion

Phase 1

Completed

• Conditions: Healthy
• Interventions: Dietary Supplement: Artificial sweeteners; Carbohydrate Sugars; Dietary Supplement: Water

• Registration Number: NCT00978900
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

The purpose of this study is to examine the influence of artificial sweeteners (aspartame, acesulfame K, sucralose) and carbohydrate sugars (glucose, fructose) on the release of gastrointestinal satiety hormones in humans.

Detailed Description

Artificial Sweeteners significantly lower energy density of foods and beverages. They are used by diabetics as sugar substitutes as well as by consumers as aids for dietary control. Despite numerous studies which show mainly no influence of artificial sweeteners on glucose metabolism and food intake, discrepancies consist about the real effects of artificial sweeteners. Studies by Blundell and Hill in 1986 have however shown that the consumption of artificial sweeteners resulted in an increase of appetite ratings; the efficiency of AS has therefore been questioned. With respect to the world wide increase in the prevalence in obesity, it seems important to clarify whether artificial sweeteners can help regulate body weight or not. This study will explore the effect of artificial sweeteners on the release of the gastrointestinal satiety hormones PYY, GLP-1, GIP and ghrelin.

Study Timeline

• Study Start: 2008-12
• Primary Completion: 2009-03
• Study Completion: 2009-07
• Status Verified: 2009-09
• Study First Submitted: 2009-09-16
• Study First Submitted QC: 2009-09-16
• Last Update Submitted: 2009-09-16
• Study First Posted: 2009-09-17
• Last Update Posted: 2009-09-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

• Healthy subject with a body-mass index of 19.0-24.5
• Normal eating habits
• Age 18-40 years
• Stable body weight for at least three months

Exclusion Criteria

• Smoking
• Substance abuse
• Regular intake of medications (except for oral contraceptives)
• Medical or psychiatric illness
• history of gastrointestinal disorders
• food allergies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Acesulfame K	Artificial sweeteners; Carbohydrate Sugars	-
Sucralose	Artificial sweeteners; Carbohydrate Sugars	-
Aspartame	Artificial sweeteners; Carbohydrate Sugars	-
Glucose	Artificial sweeteners; Carbohydrate Sugars	-
Fructose	Artificial sweeteners; Carbohydrate Sugars	-
Water	Water	-

Primary Outcome Measures

Name	Time	Method
Gastrointestinal peptide secretion	2 hour blood sampling